According to the latest equity disclosure information of the Hong Kong Stock Exchange, on June 20, 2024, Wuxi Bio (02269.HK), received non-executive director and chairman Li Ge's shareholding of 200,000 shares on the exchange at an average price of HKD 11.9171 per share, involving approximately HKD 2.3834 million.

After the increase, Li Ge's latest number of shares held is 590,457,633 shares, and his shareholding ratio has increased from 14.21% to 14.22%.